FIELD: biotechnology.
SUBSTANCE: process for detergent-free preparation of outer membrane vesicles (OMV) of Gram negative Neisseria bacteria is disclosed. Method involves culturing bacteria population up to the stage of stationary growth followed by incubation in a medium with pH higher than 8.0 and concentration of an metalchelated agent of 1–100 mm and extracting abstracted OMV.
EFFECT: proposed method ensures high output and purity of produced OMV and can be used in biotechnology in large-scale production of vaccines, containing outer membrane vesicles (OMV) of Gram negative Neisseria bacteria.
12 cl, 2 dwg, 4 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NMB1125 PROTEIN AND ITS APPLICATION IN PHARMACEUTICAL COMPOSITIONS | 2004 |
|
RU2336900C2 |
| PROTEIN NMB0928 AND ITS APPLICATION IN PHARMACEUTICAL COMPOSITIONS | 2004 |
|
RU2335505C2 |
| VACCINES WITH APPLICATION OF VESICLES BASED ON GNA 1870 OF BROAD SPECTRUM OF ACTION FOR PREVENTION OF DISEASES, CAUSED BY NEISSERIA MENINGITIDIS | 2006 |
|
RU2432962C2 |
| VACCINE COMPOSITION CONTAINING TRANSFERRIN-BINDING PROTEIN AND HSF FROM GRAM-NEGATIVE BACTERIA | 2003 |
|
RU2359696C2 |
| MULTIVALENT VACCINE OF NATIVE VESICLES OF MENINGOCOCCAL OUTER MEMBRANE, METHOD FOR MAKING AND USING IT | 2009 |
|
RU2477145C2 |
| IMPROVED Bordetella pertussis VACCINES BASED ON MUTANT GLYCOSYLTRANSFERASES LPS | 2008 |
|
RU2542667C2 |
| MENINGOCOCCAL fHBP POLYPEPTIDES | 2012 |
|
RU2567003C2 |
| IMPROVEMENTS DEALING WITH MENINGOCOCCUS OUTER MEMBRANE VESICLES | 2005 |
|
RU2420312C2 |
| VACCINE AGAINST INTERMEDIATE WITH AMYLOID COAGULATION | 2009 |
|
RU2546234C2 |
| KIT FOR PREPARING IMMUNOGENIC COMPOSITION FOR SEROGROUP B Neisseria meningitidis | 2008 |
|
RU2498815C2 |
